Follow
Zobair Younossi
Zobair Younossi
Other namesZobair M. Younossi
The Global NASH Council
Verified email at cldq.org
Title
Cited by
Cited by
Year
Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes
ZM Younossi, AB Koenig, D Abdelatif, Y Fazel, L Henry, M Wymer
Hepatology 64 (1), 73-84, 2016
99792016
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases
N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ...
Hepatology 67 (1), 328-357, 2018
62472018
The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of …
N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ...
Hepatology 55 (6), 2005-2023, 2012
49632012
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Z Younossi, QM Anstee, M Marietti, T Hardy, L Henry, M Eslam, J George, ...
Nature reviews Gastroenterology & hepatology 15 (1), 11-20, 2018
44712018
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity
CA Matteoni, ZM Younossi, T Gramlich, N Boparai, YC Liu, ...
Gastroenterology 116 (6), 1413-1419, 1999
43691999
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
G Vernon, A Baranova, ZM Younossi
Alimentary pharmacology & therapeutics 34 (3), 274-285, 2011
40052011
The utility of radiological imaging in nonalcoholic fatty liver disease
S Saadeh, ZM Younossi, EM Remer, T Gramlich, JP Ong, M Hurley, ...
Gastroenterology 123 (3), 745-750, 2002
24562002
Sofosbuvir for previously untreated chronic hepatitis C infection
E Lawitz, A Mangia, D Wyles, M Rodriguez-Torres, T Hassanein, ...
New England Journal of Medicine 368 (20), 1878-1887, 2013
24032013
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
23902020
Telaprevir for retreatment of HCV infection
S Zeuzem, P Andreone, S Pol, E Lawitz, M Diago, S Roberts, R Focaccia, ...
New England Journal of Medicine 364 (25), 2417-2428, 2011
21042011
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of …
N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ...
Gastroenterology 142 (7), 1592-1609, 2012
20832012
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
RJ Wong, M Aguilar, R Cheung, RB Perumpail, SA Harrison, ...
Gastroenterology 148 (3), 547-555, 2015
19802015
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
C Estes, H Razavi, R Loomba, Z Younossi, AJ Sanyal
Hepatology 67 (1), 123-133, 2018
19642018
Non-alcoholic fatty liver disease–a global public health perspective
ZM Younossi
Journal of hepatology 70 (3), 531-544, 2019
17712019
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis
ZM Younossi, P Golabi, L de Avila, JM Paik, M Srishord, N Fukui, Y Qiu, ...
Journal of hepatology 71 (4), 793-801, 2019
16352019
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis
PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ...
Hepatology 65 (5), 1557-1565, 2017
16262017
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ...
Hepatology 69 (6), 2672-2682, 2019
15492019
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
ZM Younossi, M Stepanova, M Afendy, Y Fang, Y Younossi, H Mir, ...
Clinical gastroenterology and hepatology 9 (6), 524-530. e1, 2011
14102011
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
ZM Younossi, D Blissett, R Blissett, L Henry, M Stepanova, Y Younossi, ...
Hepatology 64 (5), 1577-1586, 2016
12322016
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and …
E Lawitz, MS Sulkowski, R Ghalib, M Rodriguez-Torres, ZM Younossi, ...
The Lancet 384 (9956), 1756-1765, 2014
10542014
The system can't perform the operation now. Try again later.
Articles 1–20